US 9,808,416 B2
Oral care compositions and methods
Marian Georges, East Brunswick, NJ (US); Andre Michelle Morgan, Robbinsville, NJ (US); Sarita Vera Mello, North Brunswick, NJ (US); Pierre Lambert, Bottmingen (CH); and Claude Blanvalet, Angleur (BE)
Assigned to Colgate-Palmolive Company, New York, NY (US)
Filed by Colgate-Palmolive Company, New York, NY (US)
Filed on Dec. 9, 2015, as Appl. No. 14/964,175.
Prior Publication US 2017/0165192 A1, Jun. 15, 2017
Int. Cl. A61Q 11/00 (2006.01); A61K 47/38 (2006.01); A61K 6/00 (2006.01); A61K 8/92 (2006.01); A61K 8/21 (2006.01); A61K 8/81 (2006.01); A61K 8/37 (2006.01); A61K 8/25 (2006.01); A61K 8/73 (2006.01); A61K 8/34 (2006.01)
CPC A61K 8/922 (2013.01) [A61K 8/21 (2013.01); A61K 8/25 (2013.01); A61K 8/34 (2013.01); A61K 8/37 (2013.01); A61K 8/731 (2013.01); A61K 8/8147 (2013.01); A61Q 11/00 (2013.01); A61K 2800/30 (2013.01); A61K 2800/592 (2013.01)] 14 Claims
 
1. An oral care composition comprising:
3 wt % to 7 wt % of ethylcellulose;
15 wt % to 25 wt % hydrogenated rosin;
0.1 wt % to 3 wt % acetyl tributyl citrate;
1 wt % to 10 wt % sodium fluoride;
50 wt % to 70 wt % solvent, wherein the solvent is ethanol; and
1 wt % to 10 wt % fumed silica.